MENU

ESPR Esperion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ESPR is expected to report earnings to fall 47.61% to -17 cents per share on November 05

Esperion Therapeutics ESPR Stock Earnings Reports
Q3'24
Est.
$-0.17
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.29
Q4'23
Missed
by $0.03
Q3'23
Beat
by $0.06
The last earnings report on August 12 showed earnings per share of -33 cents, missing the estimate of -15 cents. With 1.76M shares outstanding, the current market capitalization sits at 495.94M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

ESPR and Stocks

Correlation & Price change

A.I.dvisor tells us that ESPR and ORGO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESPR and ORGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESPR
1D Price
Change %
ESPR100%
-0.47%
ORGO - ESPR
33%
Poorly correlated
+1.56%
CTLT - ESPR
31%
Poorly correlated
-0.63%
SCYX - ESPR
31%
Poorly correlated
+1.99%
PTPI - ESPR
29%
Poorly correlated
+14.76%
ZOM - ESPR
26%
Poorly correlated
+4.59%
More